Technical Analysis for CBPO - China Biologic Products, Inc.

Grade Last Price % Change Price Change
grade B 116.0 -0.11% -0.13
CBPO closed down 0.11 percent on Tuesday, February 25, 2020, on approximately normal volume.
Earnings due: Mar 5
*** please verify all earnings dates ***

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Flat Flat
Historical CBPO trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
Fell Below 20 DMA Bearish -0.11%
Fell Below 50 DMA Bearish -0.11%
50 DMA Support Bullish -0.80%
NR7 Range Contraction -0.80%
Three Weeks Tight Range Contraction -0.80%
Inside Day Range Contraction -0.80%
Up 3 Days in a Row Strength -0.80%
20 DMA Support Bullish -0.70%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


China Biologic Products, Inc., a biopharmaceutical company, through its subsidiaries, engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China. It offers human albumin for the treatment of shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. The company also offers human hepatitis B immunoglobulin for the prevention of measles and contagious hepatitis; human albumin and human immunoglobulin for intravenous injection (IVIG) products for original immunoglobulin deficiency, secondary immunoglobulin deficiency, and auto-immune deficiency diseases; and Thymopolypeptides injection that is used for the treatment of various original and secondary T-cell deficiency syndromes, auto-immune deficiency diseases, and a range of cell immunity deficiency diseases, as well as assists in the treatment for tumors. In addition, it provides human rabies immunoglobulin primarily for passive immunity from bites or claws by rabies or other infected animals; human tetanus immunoglobulin for the prevention and therapy of tetanus; and placenta polypeptide that is used for the treatment of cell immunity deficiency diseases, viral infection, and leucopenia caused by various reasons, as well as assists in postoperative heating. The company's products under development comprise human prothrombin complex concentrate; human hepatitis B immunoglobulin (PH4) for intravenous injection; human fibrinogen; Varicella hyperimmune globulins; and Human IVIG. It distributes its products directly or through distributors. The company is based in Beijing, the People's Republic of China.
Medicine Biopharmaceutical Immunology Antibodies Immune System Tumors Glycoproteins Rabies Hydrocephalus Immunoglobulin Therapy Measles Shock Tetanus Varicella

Is CBPO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 119.44
52 Week Low 79.13
Average Volume 88,267
200-Day Moving Average 106.54
50-Day Moving Average 116.53
20-Day Moving Average 116.39
10-Day Moving Average 116.55
Average True Range 1.07
ADX 19.13
+DI 10.16
-DI 15.32
Chandelier Exit (Long, 3 ATRs ) 114.29
Chandelier Exit (Short, 3 ATRs ) 118.22
Upper Bollinger Band 117.16
Lower Bollinger Band 115.61
Percent B (%b) 0.25
BandWidth 1.33
MACD Line 0.00
MACD Signal Line 0.02
MACD Histogram -0.0209
Fundamentals Value
Market Cap 3.16 Billion
Num Shares 27.2 Million
EPS 3.84
Price-to-Earnings (P/E) Ratio 30.21
Price-to-Sales 6.40
Price-to-Book 4.00
PEG Ratio 1.53
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 117.10
Resistance 3 (R3) 117.12 116.77 116.91
Resistance 2 (R2) 116.77 116.49 116.76 116.85
Resistance 1 (R1) 116.39 116.32 116.22 116.37 116.79
Pivot Point 116.04 116.04 115.96 116.03 116.04
Support 1 (S1) 115.66 115.76 115.49 115.64 115.21
Support 2 (S2) 115.31 115.59 115.30 115.15
Support 3 (S3) 114.93 115.31 115.09
Support 4 (S4) 114.91